Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Journal of Virology|July 1, 1990
A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infectionT M Block, J G Spivack, I Steiner, et al.
The Journal of General Virology|March 1, 1991
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal gangliaT Valyi-Nagy, S L Deshmane, J G Spivack, et al.
Journal of the Neurological Sciences|July 9, 2014
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapyM A Hellmann, N Lev, I Lotan, et al.
European Journal of Neurology|June 28, 2008
EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adultsA Chaudhuri, P Martinez-Martin, P M Martin, et al.
The EMBO Journal|February 1, 1989
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infectionI Steiner, J G Spivack, R P Lirette, et al.
Medical Hypotheses|December 21, 2004
Can a herpes simplex virus type 1 neuroinvasive score be correlated to other risk factors in Alzheimer's disease?J M Hill, B M Gebhardt, A M Azcuy, et al.
Journal of Virology|December 1, 1991
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye modelM D Trousdale, I Steiner, J G Spivack, et al.
Neurology|March 24, 2004
Rasmussen encephalitis with active inflammation and delayed seizures onsetI Korn-Lubetzki, C G Bien, J Bauer, et al.
Molecular Medicine (Cambridge, Mass.)|July 8, 2016
Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic diseaseM Amor, V Moreno Viedma, A Sarabi, et al.
Allergy|October 31, 2017
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot studyJ Eckl-Dorna, R Fröschl, C Lupinek, et al.
Pageof 18